Daily Traders Edge
Sponsored Advert
Home
Featured
Markets & Economy
Politics
Gold & Commodities
Technology
Dow Jones Newswires: Teva Pharma shares jump 17% on pending agreement over opioid litigation
Back To Homepage
July 26
19:36
2022
Share it With Friends
Teva ADRs jump 17% to $8.31 late Tuesday after the company reaches agreement in principle to resolve the majority of its opioid-related litigation.
Continue Reading At MarketWatch
Share
Share
Tweet
+1
Share
Share
Related Articles
Scroll Back To Top
The Wall Street Journal: Facebook to review its practice of separate rules for high-profile users
Europe Markets: Telecom Italia surges on deal news, as European stocks inch up after weekend of protests over COVID restrictions
More baseball games get canceled as now 18 Miami Marlins players and coaches test positive for the coronavirus
Newsletter Signup
Sign up for our free newsletter
Comments
Loading..
Close Window
Loading, Please Wait!
This may take a second or two.